Need a quote from a Motley Fool analyst? In conjunction with today's call, we have provided a presentation that will be referenced during our remarks that is posted to the Investor Relations section ...
Key combination for the treatment of Small Cell Lung Cancer MADRID and CAMBRIDGE, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results